Novo-Nordisk A/S
NVO
39.24
+0.82
+2.12%
Novo-Nordisk A/S
US · NVO
#97 by market cap
Listed 1970
39.24
+0.82
+2.12%
Live - 5344 symbols - heartbeat 517s ago
· 2026-10-20 10:50
About Novo-Nordisk A/S
Novo Nordisk is a Danish pharmaceutical company built around diabetes and obesity care — including cardiovascular and emerging related therapies — alongside a rare-disease unit covering blood disorders and hormone-replacement treatments. Harald and Thorvald Pedersen founded the company in 1923; it is headquartered in Bagsvaerd, Denmark.
- Founded
- 1923
- CEO
- Mr. Maziar Mike Doustdar
- Employees
- 69,505
- Headquarters
- Bagsv?rd, Capital Region, Denmark
- Fiscal year end
- 12-31
- Website
- novonordisk.com
Company profile
- Exchange
- US
- Symbol
- NVO
- Market-cap rank
- #97
- Listing date
- 1970-01-01
- Market cap
- 175.18B
- Float cap
- 125.16B
- Shares out
- 4.47B
- Float shares
- 3.19B
Sectors & themes
Quote time 2026-10-20 10:50:14 · For reference only, not investment advice and not tailored to your situation.
Novo-Nordisk A/S discussion 0 comments